Kerala Ayurveda Ltd.

BSE: KERALAYUR · Pharmaceuticals · sector

₹137.40BSE close 2026-10-26

Key numbers

Market cap₹179 cr

Price₹137.40

52w high / low₹448 / ₹137

P/E6.0xSector median 27.9x

P/B16.1xSector median 2.9x

Book value₹8.6

Dividend yield–Sector median 0.48%

ROE-257.3%Sector median 11.7%

ROCE-19.7%Sector median 12.3%

OPM-12.8%Sector median 14.0%

Debt / equity7.27xSector median 0.16x

EV/EBITDA–Sector median 18.6x

Interest cover-1.9x

Current ratio0.45x

Sales growth 3y+30.4%Sector median +9.6%

Profit growth 3y–Sector median +13.3%

PEG0.08x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹6 cr vs borrowings ₹81 cr (FY26): borrowings are higher by ₹75 cr.
Operating profit covered interest -1.9x in the last 12 months.
Net loss in 5 of the last 6 quarters.
No dividend in the last 5 financial years.
Price ₹137.40 on 2026-10-26: -69.3% from the 52-week high, 0.0% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹600.65 · low ₹137.40

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	31	29	35	33	35	33
EBITDA	-10	-4	-5	-2	-7	-4
OPM %	-32.4%	-14.6%	-14.2%	-4.6%	-20.4%	-11.5%
Other income	1	9	2	1	2	0
Net profit	-16	2	-6	-4	-8	-8
EPS (₹)	13.68	1.92	7.23	3.69	5.83	6.24
Revenue YoY					+10.9%	+16.0%
Profit YoY					–	-445.5%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	52	59	68	120	131	136
EBITDA	8	7	4	-5	-18	-17
Net profit	1	3	-0	-15	-17	-27
EPS (₹)	1.17	5.77	-0.25	12.79	30.53	22.99
Revenue growth		+14.3%	+14.4%	+78.0%	+9.0%	–
Profit growth		+224.7%	-109.3%	–	–	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+30.4%	–	–
Net profit	–	–	–
EPS	+74.3%	–	–
Share price	–	-27.5% (2y)	-67.8%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	9	11
Borrowings	66	81
Cash & equivalents	3	6
Total assets	129	138
Fixed assets	31	33
Capital work in progress	9	8
Investments	0	0
Receivables	19	14
Inventory	13	15
Payables	6	10

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	5	-24
Cash from investing	-15	-5
Cash from financing	-9	32
Capex	13	6
Free cash flow	-8	-30

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	-154.8%	-148.9%
ROCE %	-10.8%	-9.8%
Debtor days	59	38
Inventory days	208	200
Payable days	93	129
Cash conversion cycle (days)	174	109
Working capital days	-144	-152

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
KERALAYUR	₹179 cr	6.0x	16.1x	-257.3%	-19.7%	-12.8%	+30.4%	–

All 185 companies in Pharmaceuticals →

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	KERALAYUR
BSE code	530163
ISIN	INE817B01025
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.